Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NoronexASX:NRX 3-Year EBITDA Growth Rate is 41.50% as of Dec. 2025, which is 47% above its 10-year median of 28.30. The stock has 2 warning signs investors should review. Among 2,116 Metals & Mining companies, Noronex ranks better than 81.33% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 41.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 24.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Noronex was 45.40% per year. The lowest was -20.80% per year. And the median was 28.30% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Noronex 3-Year EBITDA Growth Rate Related Terms
ASX:NRX vs SCCO, FCX: 3-Year EBITDA Growth Rate Comparison
For the Copper subindustry, Noronex's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noronex 3-Year EBITDA Growth Rate vs Metals & Mining Industry
For the Metals & Mining industry and Basic Materials sector, Noronex's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Noronex's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 41.50% mean?
Noronex (ASX:NRX) has a 3-Year EBITDA Growth Rate of 41.50% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Noronex and its competitors. This is 47% above median its historical median of 28.30. According to the industry distribution chart, Noronex ranks #395 out of 2116 companies in the Metals & Mining industry, placing it in the top 18.7%.
Is Noronex's 3-Year EBITDA Growth Rate too high?
Noronex's current 3-Year EBITDA Growth Rate of 41.50% is 47% above median its 10-year median of 28.30. The Metals & Mining industry median 3-Year EBITDA Growth Rate is 15.75. Noronex's value of 41.50% is 163.5% above this industry median. Based on the distribution chart, Noronex ranks #395 out of 2116 companies in the Metals & Mining industry, which is in the top quartile — a strong position relative to peers.
How does Noronex's 3-Year EBITDA Growth Rate compare to SCCO and FCX?
According to the Metals & Mining industry distribution chart, Noronex ranks #395 out of 2116 companies for 3-Year EBITDA Growth Rate. This places Noronex in the top 19% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 15.75. Noronex's value of 41.50% is 163.5% above this benchmark. While the company's 10-year median is 28.30 vs. the industry median of 15.75, Noronex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Metals & Mining company?
The median 3-Year EBITDA Growth Rate among Metals & Mining companies is 15.75, based on 2,116 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Noronex's current 3-Year EBITDA Growth Rate of 41.50% is 163.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Noronex and its competitors. For the Metals & Mining industry, the median 3-Year EBITDA Growth Rate is 15.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noronex's current 3-Year EBITDA Growth Rate is 41.50%, which is 47% above median its own 10-year median of 28.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noronex stock overvalued right now?
Noronex (ASX:NRX) has a current 3-Year EBITDA Growth Rate of 41.50%. The current 3-Year EBITDA Growth Rate is 41.50%, which is 47% above median its 10-year median of 28.30 and 163.5% above the Metals & Mining industry median of 15.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Noronex (ASX:NRX), the current 3-Year EBITDA Growth Rate is 41.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Noronex Ltd is a mineral exploration company, identifying projects in Australia. The company holds a portfolio of high-grade copper projects in Canada and an option to acquire three prospecting licences that are prospective for sedimentary Cu-Ag mineralization along the prolific Kalahari Copper Belt that spans Namibia and Botswana. The group operates in the mineral exploration sector predominantly in Australia, Namibia, and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:NRX has been successfully added to your 
